Home / Products / Cancer / Urothelial Carcinoma

Urothelial Carcinoma


Available treatments for Urothelial Carcinoma
You can order a treatment for Urothelial Carcinoma via TheSocialMedwork if it has not been approved and/or is not available in the patient's country. TheSocialMedwork - helping patients and doctors access the latest approved medicines and at the lowest price possible worldwide.
drip
View Product

Imfinzi

(durvalumab)

by: AstraZeneca
for: Bladder Cancer
from: 1449.50
• FDA approved (USA)
drip
View Product

Keytruda

(pembrolizumab)

by: Merck & co
for: Head and Neck Cancer / Lung Cancer / Urothelial Carcinoma / Skin Cancer / Lymphoma / MSI-H or dMMR solid tumours / Gastric Cancer
from: 1626.50
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

drip
View Product

Opdivo

(nivolumab)

by: Bristol-Myers Squibb
for: Colorectal Cancer / Head and Neck Cancer / Hodgkin Lymphoma / Kidney Cancer / Lung Cancer / Skin Cancer / Bladder Cancer / Liver Cancer
from: 585.38
• EMA approved (EU)
• FDA approved (USA)
• PMDA approved (JAP)
• TGA approved (AUS)

drip
View Product

Tecentriq

(atezolizumab)

by: Genentech
for: Lung Cancer / Bladder Cancer
from: 6455.85
• EMA approved (EU)
• FDA approved (USA)
• TGA approved (AUS)

unknown
Enquire now

We may still be able to get it for you, provided that:

• it hasn't been approved and/or isn't available in your country
• you and your treating doctor have evaluated that the medicine is suitable for you, and your doctor writes a prescription for it.


About urothelial carcinoma

Urothelial cancers are a multifocal process which encompasses carcinomas of the bladder, ureters, and renal pelvis at a ratio of 50:3:1 [1]. Urothelial carcinoma, also known as transitional cell carcinoma (TCC), is by far the most common type of bladder cancer which starts in the urothelial cells that line the inside of the bladder. Urothelial cells also line other parts of the urinary tract, such as the part of the kidney that connects to the ureter, the ureters, and the urethra. Patients with bladder cancer sometimes have other tumors in these places, so the entire urinary tract needs to be checked for tumors [2].

The global incidence in 2012 for bladder cancer was 430,000 [3]. Patients with cancer of the upper urinary tract have a 30% to 50% chance of developing cancer of the bladder at some point in their lives. On the other hand, patients with bladder cancer have a 2% to 3% chance of developing cancer of the upper urinary tract [1].

The above products may be suitable for treating patients with urothelial carcinoma. We recommend that you discuss the suitability of possible treatment options with your doctor. For further information please contact our support team at support@thesocialmedwork.com.


Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.



Share our website

Follow us


DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision. Privacy Policy / Terms and Conditions
Our service uses cookies.